logo
EU to Ease Clozapine Monitoring Frequency After First Year

EU to Ease Clozapine Monitoring Frequency After First Year

Medscape14-07-2025
The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee has recommended easing routine blood count monitoring for patients on clozapine, citing new data that show that the risk for severe neutropenia and agranulocytosis declines significantly after the first year of treatment.
Under the updated guidelines, monitoring for patients without a history of neutropenia can be reduced to once every 12 weeks after the first year, and to once annually after 2 years. In addition, absolute neutrophil count (ANC) will now be the sole parameter used for hematologic monitoring, replacing the previous requirement to also measure white blood cell count.
The revised recommendations are supported by a joint expert statement from the European Clozapine Task Force, published this year, which called for changes to the monitoring protocol due to the very low incidence of late-onset agranulocytosis.
Additional evidence comes from a large-scale study involving more than 26,000 patients, which found that clozapine-induced severe neutropenia peaked around week 9 (0.128% weekly incidence) and declined sharply after week 18, with rates becoming negligible — 0.001% per week — after 2 years of continuous use.
Mechanism and Risk Profile
Clozapine is an atypical antipsychotic indicated for treatment-resistant schizophrenia and for patients who cannot tolerate other antipsychotics due to neurologic side effects. It is also used to manage psychosis associated with Parkinson's disease when standard treatments fail.
Clozapine works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, contributing to its unique efficacy in refractory schizophrenia. However, it carries a known risk for drug-induced neutropenia and its most severe form, agranulocytosis.
Research suggests that a reactive metabolite of clozapine, the nitrenium ion, may bind to neutrophil proteins. This complex is then thought to act as a hapten, triggering an immune response that leads to the destruction of neutrophils, a process for which certain individuals may have a genetic predisposition.
All clozapine-containing products in the European Union will be updated to reflect the new ANC-based monitoring schedule and thresholds for treatment initiation and continuation. The direct healthcare professional communication will be distributed by the marketing authorization holders in coordination with national authorities, and published on EMA and national regulatory websites.
Clinicians are encouraged to review and update monitoring protocols accordingly and continue reporting suspected adverse events through established pharmacovigilance channels.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctors Were Worse at Spotting Cancer After Leaning on AI, Study Finds
Doctors Were Worse at Spotting Cancer After Leaning on AI, Study Finds

Gizmodo

time25 minutes ago

  • Gizmodo

Doctors Were Worse at Spotting Cancer After Leaning on AI, Study Finds

Artificial intelligence tools have been shown to help doctors detect pre-cancerous growths in the colon—but don't even think about taking those tools away once you've introduced them. A new study published this week in The Lancet found that doctors who are given AI tools to assist with identifying potential cancer risks in patients get worse at making those same observations when they go back to doing it without AI's help. The study looked at four endoscopy centers in Poland, tracking the success rates of detecting colon cancer for three months before AI tools were introduced and three months after. Once AI was introduced, colonoscopies were randomly assigned to either receive AI support or not. The researchers found that doctors who gave colonoscopies without AI after having its assistance available saw their detection rates drop, producing outcomes 20% worse than what they were before AI was introduced. Making the results all the more troubling is the fact that the 19 doctors who participated in the study were all very experienced and had performed more than 2,000 colonoscopies each. If those doctors can fall prey to de-skilling, seeing their own abilities erode because of reliance on AI tools, the outcomes from inexperienced doctors could be even worse. There is little doubt that AI tools can help in medical settings. There have been numerous studies that suggest that AI can facilitate everything from the detection of cancers to the diagnosis of illnesses based on a patient's medical history. Analyzing information based on a whole wealth of previous examples is kinda the bread and butter of AI (you know, as opposed to generating braindead content slop), and there is evidence that suggests that humans can augment their own abilities by using AI tools. Studies in medical settings have found that doctors who use these tools can produce better outcomes for their patients. But no one, including doctors, is immune to the risk of shutting your brain off and relying on AI rather than their own skills. Earlier this year, Microsoft published a study that found knowledge workers who lean on AI stop thinking critically about the work they are doing and feel confident that the assistance from AI will be enough to get the job done. Researchers at MIT similarly found that relying on ChatGPT for essay writing resulted in less critical engagement with the material. In the long term, there's a real risk that reliance on AI will erode our ability to problem solve and reason, which is not ideal when AI continues to generate bad information. The American Medical Association found that about two in three physicians have already adopted AI to augment their abilities. Hopefully, they're still able to identify when it does something like hallucinating a body part that doesn't exist.

Human Touch Meets Neuroscience: Integrating Access Bars® as the Future of Workplace Wellness
Human Touch Meets Neuroscience: Integrating Access Bars® as the Future of Workplace Wellness

Entrepreneur

time3 hours ago

  • Entrepreneur

Human Touch Meets Neuroscience: Integrating Access Bars® as the Future of Workplace Wellness

You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. In an era saturated with AI and digital solutions, something profound is being forgotten: the simple power of presence and human touch. Access Bars®, a gentle, hands-on wellness modality, is gaining traction as a corporate ally in nurturing employee well-being. As organizations strive to integrate high-tech solutions, Access Bars invites time to pause, receive, and experience meaningful human connection. From the moment people step into the workplace, the subtle but ceaseless hum of stress follows them. Their brains chatter and minds race, pressured by productivity demands and digital overload. Access Bars disrupts this cycle, not with another task on the to-do list, but with a deliberate invitation to rest. "It's not another item on your agenda; you simply lie back and receive the session," asserts Mia DeLuca, a Biologist and Holistic Wellness Advocate at Access Bars. "It reframes well-being as an experience, not an action." Grounded in emerging research, Access Bars is not just comforting, it's compelling. A recent live case study led by Dr. Astrid Vester, Physician and Integrative Medicine Leader, alongside DeLuca, examined real-time physiological responses to Access Bars sessions versus resting controls. In an era where burnout and mental fatigue are at an all-time high, new research finds that Access Bars sessions, the foundational technique of the Bars in Business program, can create measurable improvements in stress, physiological health, and mental clarity. These findings possibly make it a powerful tool for modern workplaces. These changes in individuals may further help restore the human element of caring for oneself and others. In office space, amid conference calls, people increasingly crave contact that's not mediated by screens. A light touch to 32 points on the head, held for 30-45 minutes, opens a gateway to deep relaxation, akin to meditation, yet effortless and accessible. "The human touch evokes trust and openness," reflects Dr. Vester. "In that tranquil space, the brain can shift, drop into coherence, and employees reset not just their stress, but their capacity for creativity." Businesses are noticing not just the experiential value but the measurable payoff. One study from Zippia reports that 72% of companies observed reduced healthcare costs after launching wellness programs, with an average ROI of 6:1, and absenteeism was reduced by up to 16%. Additionally, a whopping 87% of workers consider wellness offerings when choosing an employer. Nearly three-quarters (74%) of organizations plan to increase spending on wellness in 2025, and 80% of forward-thinking HR departments are weaving wellness into their employee value propositions. These figures illustrate a shifting mindset: wellness is not a perk, it's a strategic imperative. Pilot programs aim for the ripple effects of a session to go beyond individual relief and to inform team dynamics. One of the organizations that implemented weekly Access Bars for front-line staff noted improved decision-making, increased confidence, and a workplace atmosphere marked by mutual openness. It's not just self-care; it's collective well-being. In fast-changing corporate environments, what if inspiration and innovation were less about pushing harder and more about creating breathing room? Access Bars cultivates that, quieting the racing mind and replenishing the brain's internal capacity to think clearly, connect intuitively, and respond rather than react. Another executive from a global firm captured its value perfectly: "In changing times, programs like this are vital for retention and stress management. It improved morale, engagement, and relaxed the work environment." This type of forward-looking leadership invests in internal resilience to drive external performance. The gift of Access Bars is not about productivity at all. It's about honoring humanity. "Employees don't need another checkbox; they need a moment to just be," DeLuca emphasizes. "The human touch is countercultural in today's efficiency-obsessed world. But that's the point. Access Bars plants a seed: wellness doesn't demand action; it simply welcomes reception. When organizations acknowledge that some of the most powerful healing and innovation happen when we rest, they create a new paradigm of well-being." Integrating Access Bars into HR wellness strategies can be simple: a quiet session room, 30 minutes, and the willingness to experience the relaxation. Studies show that the return on investment for a $1 investment in wellness could mean a benefit-to-cost ratio of up to $6. That gives room for true creativity. Dr. Vester says, "Healthcare is evolving from prescribing fixes to facilitating restful presence. Access Bars embodies that shift." Furthermore, DeLuca adds, "It's not about fixing people, it's about remembering they are worthy of care simply because they are human." When human touch meets scientific curiosity, the result is more than a momentary pause; it's a reconnection to what makes work feel meaningful. For companies seeking sustainable performance, Access Bars in Business might just be the gentle change they never knew they needed.

Rock Tech Receives Further Research Funding From German Government
Rock Tech Receives Further Research Funding From German Government

Yahoo

time5 hours ago

  • Yahoo

Rock Tech Receives Further Research Funding From German Government

After having received funding from EIT Raw Materials, a body of the European Union, the Federal Ministry for Research, Technology and Space has selected Rock Tech for funding in the lithium field. Rock Tech will collaborate with research partners from RWTH Aachen University (Rheinisch-Westfälische Technische Hochschule Aachen), one of Europe's leading technical universities, especially renowned for its strong competencies in engineering and applied sciences. TORONTO, Aug. 12, 2025 /PRNewswire/ - Rock Tech Lithium Inc. (TSXV: RCK) (OTCQX: RCKTF) (FWB: RJIB) (WKN: A1XF0V) (the "Company" or "Rock Tech") is pleased to announce that it has been awarded funding from the Bundesministerium für Forschung, Technologie und Raumfahrt (Federal Ministry for Research, Technology and Space) for the project "ELiSePro – Efficient Lithium Recovery Using Selective Processes". The aim of this initiative is to further increase lithium yield in our converter process at the Guben site, making a significant contribution to Germany's raw material independence. The project will be implemented in collaboration with RWTH Aachen University, highlighting the strong partnership between industry and leading academic research in Germany. The total funding amount is approximately 250,000 Euros. As part of the project, various state-of-the-art ion separation methods (including nanofiltration, capacitive deionization, and lithium-ion sieves) will be systematically compared to minimize lithium losses in the process. The results will be evaluated based on economic and technological criteria and are intended for direct industrial application in our Guben converter in order to increase our recovery. Innovative findings will also be published in scientific journals and be patented. "This funding supports the technological advancement of the German and European battery industry – and even it's a relatively small amount, it's an important step towards building additional know-how for strengthening security of supply for critical raw materials and building sustainable value chains in Europe" says Mirco Wojnarowicz, CEO of Rock Tech. In the past few months, Rock Tech has received funding from several public sources, to become a technological leader in lithium processing. This new funding underlines the strategic relevance of Rock Tech and its projects in Canada and Germany, the latter one of which was selected as strategic project under the EU Critical Raw Materials Act (CRMA). After having granted funding from EIT RawMaterials under the prestigious KAVA (Knowledge and Innovation Activities) grant program (800,000 Euros) as well as from Ontario's Critical Minerals Innovation Fund (CMIF) to advance lithium ore sorting technologies (388,000 CAD), this new funding is the third program to position Rock Tech as strategic relevant player in the lithium industry. On behalf of the Company,Mirco WojnarowiczCEO ABOUT ROCK TECHRock Tech's vision is to supply the electric vehicle and battery industry with sustainable, locally produced lithium, targeting a 100% recycling rate. To ensure resilient supply chains, the company plans to build lithium converters at the doorstep of its customers, beginning with the Company's proposed Lithium Hydroxide Converter in Guben, Brandenburg, Germany. The second Converter is planned to be built in, Ontario, Canada. Rock Tech Lithium plans to source raw material from its own Georgia Lake spodumene project in the Thunder Bay Mining District of Ontario, Canada, and procure from other ESG-compliant mines. Ultimately, Rock Tech's goal is to create a closed-loop lithium production system. Rock Tech has gathered one of the strongest teams in the industry to close the most pressing gap in the clean mobility story. The Company has adopted strict environmental, social and governance standards and is developing a proprietary refining process to increase efficiency and sustainability further. Rock Tech Lithium Inc, 2700-40 Temperance Street, Toronto ON M5H 0B4 CAN. CAUTIONARY NOTE CONCERNING FORWARD-LOOKING INFORMATION Certain statements contained in this news release constitute "forward-looking information" under applicable securities laws and are referred to herein as "forward-looking statements". All statements, other than statements of historical fact, which address events, results, outcomes or developments that the Company expects to occur are forward-looking statements. When used in this news release, words such as "expects", "anticipates", "plans", "predicts", "believes", "estimates", "intends", "targets", "projects", "forecasts", "may", "will", "should", "would", "could" or negative versions thereof and other similar expressions are intended to identify forward-looking statements. In particular, this press release contains forward-looking information pertaining to expectations concerning the Guben Converter, including the design and features of the Guben Converter, as well as the expected costs, capital expenditures, timing and outcomes thereof; statements regarding the Company's future plans, estimates, and schedules relating to the Guben Converter, including the anticipated timing of future activities taken in support of the development thereof; Rock Tech's potential financing arrangements; the expected funding from the Federal Ministry of Research, Technology and Space for the project ELiSePro as well as from EIT RawMaterials under the KAVA program and the CMIF, the expected economic performance of the Guben Converter and anticipated production of battery-grade Lithium Hydroxide and related processing methods and innovation employed; the estimated capital and operating costs of the Guben Converter; the anticipated timing and outcomes of a final investment decision, construction activities and commissioning of the Guben Converter; statements regarding the Company's sustainability and ESG related goals and strategy, including the benefits and achievement thereof and future actions taken by the Company in relation thereto; expected regulatory processes and final outcomes; expectations regarding the electric vehicle industry, including the demand for and pricing of battery-grade Lithium Hydroxide and the benefits therefrom, and the development of political and regulatory frameworks especially in Germany and the European Union; Rock Tech's opinions, beliefs and expectations regarding the Company's business strategy, development and exploration opportunities and projects; and plans and objectives of management for the Company's operations and properties. Forward-looking statements by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from the forward-looking statements, including the risks, uncertainties and other factors discussed in the Company's most recent management's discussion and analysis and annual information form filed with the applicable securities regulators. No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, and the Company cautions the reader not to place undue reliance upon any such forward-looking statements. The Company does not intend, nor does it assume any obligation to update or revise any of the forward-looking statements, whether as a result of new information, changes in assumptions, future events or otherwise, except to the extent required by applicable law. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. View original content to download multimedia: SOURCE Rock Tech Lithium Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store